Insights on Drug Policy: Prohibition vs Legalization

What has been corrected on this page?

Every accepted correction to this page is recorded with the exact change, so readers can see how the page improved over time.

1. 12 July 2026 · corrected by Emir Baycan

   2 corrections applied: The psilocybin vs escitalopram NEJM trial was published in 2021, not 2022 (matches References) | Researcher's name is Deborah S. Hasin, not Marica Hasin

   Before

   A 2022 New England Journal of Medicine paper by Robin Carhart-Harris / A 2019 JAMA Psychiatry study by Marica Hasin and colleagues

   After

   A 2021 New England Journal of Medicine paper by Robin Carhart-Harris / A 2019 JAMA Psychiatry study by Deborah S. Hasin and colleagues

   Why: Verified both fixes already fully applied in article body and references list (correct year 2021 and correct name Deborah S. Hasin present throughout). No secondary leftovers found in FAQ.

   View the full record →

Who checked this page?

1 contributor has checked "Insights on Drug Policy: Prohibition vs Legalization" on When Notes Fly. Each name below links to that person's public CitePep profile, where every contribution they have made is listed with the exact change they proposed.